Venkatachari Narasimhan J, Jain Siddhartha, Walker Leah, Bivalkar-Mehla Shalmali, Chattopadhyay Ansuman, Bar-Joseph Ziv, Rinaldo Charles, Ragin Ann, Seaberg Eric, Levine Andrew, Becker James, Martin Eileen, Sacktor Ned, Ayyavoo Velpandi
aDepartment of Infectious Diseases & Microbiology, Graduate School of Public Health, University of Pittsburgh bComputer Science Department, School of Computer Science, Carnegie Mellon University cMolecular Biology Information Service, University of Pittsburgh dComputational Biology and Machine Learning Department, Carnegie Mellon University, Pittsburgh, Pennsylvania eDepartment of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois fDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland gDepartment of Neurology, David Geffen School of Medicine, University of California Los Angeles, California hDepartment of Psychiatry, Rush University Medical Center, Chicago, Illinois iDepartment of Neurology, Johns Hopkins Bayview Medical Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
AIDS. 2017 Mar 13;31(5):623-633. doi: 10.1097/QAD.0000000000001379.
HIV-1 viral proteins and host inflammatory factors have a direct role in neuronal toxicity in vitro; however, the contribution of these factors in vivo in HIV-1-associated neurocognitive disorder (HAND) is not fully understood. We applied novel Systems Biology approaches to identify specific cellular and viral factors and their related pathways that are associated with different stages of HAND.
A cross-sectional study of individuals enrolled in the Multicenter AIDS Cohort Study including HIV-1-seronegative (N = 36) and HIV-1-seropositive individuals without neurocognitive symptoms (N = 16) or with mild neurocognitive disorder (MND) (N = 8) or HIV-associated dementia (HAD) (N = 16).
A systematic evaluation of global transcriptome of peripheral blood mononuclear cells (PBMCs) obtained from HIV-1-seronegative individuals and from HIV-1-positive men without neurocognitive symptoms, or MND or HAD was performed.
MND and HAD were associated with specific changes in mRNA transcripts and microRNAs in PBMCs. Comparison of upstream regulators and TimePath analyses identified specific cellular factors associated with MND and HAD, whereas HIV-1 viral proteins played a greater role in HAD. In addition, expression of specific microRNAs - miR-let-7a, miR-124, miR-15a and others - were found to correlate with mRNA gene expression and may have a potential protective role in asymptomatic HIV-1-seropositive individuals by regulating cellular signal transduction pathways downstream of chemokines and cytokines.
These results identify signature transcriptome changes in PBMCs associated with stages of HAND and shed light on the potential contribution of host cellular factors and viral proteins in HAND development.
HIV-1病毒蛋白和宿主炎症因子在体外对神经元毒性有直接作用;然而,这些因素在体内对HIV-1相关神经认知障碍(HAND)的作用尚未完全明确。我们应用新的系统生物学方法来识别与HAND不同阶段相关的特定细胞和病毒因子及其相关途径。
一项横断面研究,研究对象为参加多中心艾滋病队列研究的个体,包括HIV-1血清阴性者(N = 36)、无神经认知症状的HIV-1血清阳性个体(N = 16)、患有轻度神经认知障碍(MND)者(N = 8)或患有HIV相关痴呆(HAD)者(N = 16)。
对从HIV-1血清阴性个体以及无神经认知症状、患有MND或HAD的HIV-1阳性男性获取的外周血单核细胞(PBMC)的整体转录组进行系统评估。
MND和HAD与PBMC中mRNA转录本和微小RNA的特定变化相关。上游调节因子比较和TimePath分析确定了与MND和HAD相关的特定细胞因子,而HIV-1病毒蛋白在HAD中起更大作用。此外,发现特定微小RNA(如miR-let-7a、miR-124、miR-15a等)的表达与mRNA基因表达相关,并且可能通过调节趋化因子和细胞因子下游的细胞信号转导途径,对无症状HIV-1血清阳性个体具有潜在保护作用。
这些结果确定了与HAND阶段相关的PBMC特征性转录组变化,并揭示了宿主细胞因子和病毒蛋白在HAND发展中的潜在作用。